Skip to main content
. 2022 Nov 2;57(Suppl 1):100–416. doi: 10.1038/s41409-022-01798-0
MSD N = 62 HAPLO N = 55 MMUD N = 46 MUD N = 55 P
Age 49.0 [41.0;57.0] 53.0 [40.5;62.0] 45.0 [38.0;55.0] 54.0 [39.2;61.0] 0.073
HCT-CI > 1 12 (19.4%) 16 (29.1%) 7 (15.2%) 19 (34.5%) 0.086
MA-Bu 52 (83.9%) 36 (65.5%) 38 (82.6%) 39 (70.9%)
RIC-Flu/Mel 10 (16.1%) 19 (34.5%) 8 (17.4%) 16 (29.1%)
Bone marrow 2 (3.23%) 0 (0.00%) 5 (10.9%) 2 (3.64%)
Peripheral blood prog. cells 60 (96.8%) 55 (100%) 41 (89.1%) 53 (96.4%) 0.05
Acute leukemia 32 (51.6%) 30 (54.5%) 26 (56.5%) 32 (58.2%) 0.250
Myelodysplastic syndrome 9 (14.5%) 13 (23.6%) 11 (23.9%) 15 (27.3%)
Other 21 (33.9%) 12 (21.8%) 9 (19.6%) 8 (14.5%)